Henry Ford Cancer Institute/Henry Ford Health System

Detroit, Michigan 48202

2 studies enrolling now · 3 studies all time

What they study most

Head and Neck Squamous Cell Carcinoma (HNSCC), KRAS Activating Mutation, Melanoma, Non Small Cell Lung Cancer

Studies at this site

• A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Recruiting now
• A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) — Recruiting now
• A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer — Completed